glp-1 agonists with cardiovascular benefit Benefits and drawbacks of receptor agonist use. Abbreviations: GLP-1 receptor agonists: The cardiovascular
Description
Nakamura Regulatory Affairs Lead, APAC
The obesity segment is expected to be the fastest-growing due to increased insurance coverage, favorable cardiovascular outcome and recognition of obesity as a chronic disease
We are advocating within Canada for coverage of these
Mfazo Hove
The drug also carries a boxed warning for a potential risk of thyroid tumours and is not recommended for use alongside other GLP-1 therapies.
10.1007/s11096-023-01556-2 14 CasanovasG
